These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Elmore AR; Int J Toxicol; 2003; 22 Suppl 1():37-102. PubMed ID: 12851164 [TBL] [Abstract][Full Text] [Related]
24. The Impact of Cosmetics on the Physical Dimension and Optical Performance of Contemporary Silicone Hydrogel Contact Lenses. Luensmann D; van Doorn K; May C; Srinivasan S; Jones L Eye Contact Lens; 2020 May; 46(3):166-173. PubMed ID: 31232789 [TBL] [Abstract][Full Text] [Related]
25. Eye Make-up Products and Dry Eye Disease: A Mini Review. Yazdani M; Elgstøen KBP; Utheim TP Curr Eye Res; 2022 Jan; 47(1):1-11. PubMed ID: 34365876 [TBL] [Abstract][Full Text] [Related]
26. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
27. Further verification of an in vitro tier system for the identification of cosmetic ingredients that are not ocular irritants. Hagino S; Okazaki Y; Kitagaki M; Itagaki H Altern Lab Anim; 2010 May; 38(2):139-52. PubMed ID: 20507185 [TBL] [Abstract][Full Text] [Related]
28. Final report on the safety assessment of Hexamidine and Hexamidine Diisethionate. Int J Toxicol; 2007; 26 Suppl 3():79-88. PubMed ID: 18273451 [TBL] [Abstract][Full Text] [Related]
29. Safety in Cosmetics and Cosmetovigilance, Current Regulations in Türkiye. Altıokka İ; Üner M Turk J Pharm Sci; 2022 Oct; 19(5):610-617. PubMed ID: 36317955 [TBL] [Abstract][Full Text] [Related]
30. Final report of the safety assessment of niacinamide and niacin. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2005; 24 Suppl 5():1-31. PubMed ID: 16596767 [TBL] [Abstract][Full Text] [Related]
31. Potential Cosmetic Active Ingredients Derived from Marine By-Products. Siahaan EA; Agusman ; Pangestuti R; Shin KH; Kim SK Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547881 [TBL] [Abstract][Full Text] [Related]
32. Ocular disorders due to eyelash extensions. Amano Y; Sugimoto Y; Sugita M Cornea; 2012 Feb; 31(2):121-5. PubMed ID: 22134404 [TBL] [Abstract][Full Text] [Related]
33. Consumer exposure to certain ingredients of cosmetic products: The case for tea tree oil. Rieder BO Food Chem Toxicol; 2017 Oct; 108(Pt A):326-338. PubMed ID: 28818687 [TBL] [Abstract][Full Text] [Related]
35. Cosmetics and Personal Care Products-Related Ocular Exposures Reported to United States Poison Control Centers. Kamboj A; Spiller HA; Funk AR; Badeti J; Smith GA Ophthalmic Epidemiol; 2022 Oct; 29(5):573-581. PubMed ID: 34551657 [TBL] [Abstract][Full Text] [Related]
37. A perspective on the safety of cosmetic products: a position paper of the American Council on Science and Health. Ross G Int J Toxicol; 2006; 25(4):269-77. PubMed ID: 16815815 [TBL] [Abstract][Full Text] [Related]
38. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160 [TBL] [Abstract][Full Text] [Related]
39. [Esthetics, cosmetics and ophthalmology]. Kassir M; Tham-Kassir H J Fr Ophtalmol; 2001 May; 24(5):537-45. PubMed ID: 11397994 [TBL] [Abstract][Full Text] [Related]